Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations
- 1 April 2005
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 33 (4) , 469-479
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- FLT3 mutations in childhood acute lymphoblastic leukemiaBlood, 2004
- FLT3: ITDoes matter in leukemiaLeukemia, 2003
- The role of FLT3 in haematopoietic malignanciesNature Reviews Cancer, 2003
- FLT3 and its Role in the Pathogenesis of Acute Myeloid LeukaemiaLeukemia & Lymphoma, 2003
- Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr–Abl signal transduction and oncogenesisOncogene, 2002
- Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domainOncogene, 2002
- Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cellsBlood, 2001
- Src Family Kinases Negatively Regulate Platelet-derived Growth Factor α Receptor-dependent Signaling and Disease ProgressionJournal of Biological Chemistry, 2000
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970